Cyrus Amoozegar is an equity research analyst specializing in healthcare. He joined Jennison in 2022. Previously, Cyrus was an analyst at Eversept Partners where he focused on therapeutics and healthcare. Prior to that, he was an equity research associate at Morgan Stanley supporting the large cap biotechnology team. Cyrus earned dual BSEs in biomedical engineering and mechanical engineering from Duke University’s Pratt School of Engineering, and a PhD in biomedical engineering as well as an MD from Columbia University.